Analystreport

IntelliPharmaCeutics Intl Inc (NASDAQ: IPCI) had its price target raised by analysts at S&P Equity Research from $0.87 to $1.11.

INTELLIPHARMACEUTICS  (IPCI) 
Last intellipharmaceutics earnings: 10/15 05:15 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.intellipharmaceutics.com